If you have any questions or concerns about how these changes might affect you, call us at 1-888-376-2028
That experience is real and worth reviewing, but it is not enough on its own to prove the medicine has stopped working
Ellenbroek JH, Tons HA, Westerouen van Meeteren MJ, de Graaf N, Hanegraaf MA, Rabelink TJ, Carlotti F, and de Koning EJ
The supplier company is located in Zhoushan, Zhejiang Sheng, and is one of the leading sellers of listed products
MASH improvement (no fibrosis worsening) at 2.4mg: 47% MASH improvement (no fibrosis worsening) at 4.8mg: 62% MASH improvement (no fibrosis worsening) at 6.0mg: 43% Placebo MASH improvement: 14% Liver fat reduction of 30%+ at 4.8mg: 67% Fibrosis improvement by 1+ stage: 34-36% These results led to FDA Breakthrough Therapy designation, which accelerates the development and review process for drugs addressing serious conditions
Abrupt discontinuation is not recommended, particularly at higher maintenance doses